Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
23 hedge funds and large institutions have $31.3M invested in Global Cord Blood Corporation in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
109% more call options, than puts
Call options by funds: $167K | Put options by funds: $80K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 24 → 23 (-1)
19% less capital invested
Capital invested by funds: $38.7M → $31.3M (-$7.45M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$6.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$188 |
| 2 |
MGIA
Moneta Group Investment Advisors
St Louis,
Missouri
|
-$42 |
CO Hedge Fund Activity: Q4 2022 in Review
23 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2022, worth a combined $31.3M — down 19% from $38.7M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CO and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Simplex Trading, adding an estimated $6.3K. The largest seller was Morgan Stanley, cutting an estimated $188.
- 23 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2022, down from 24 in Q3 2022.
- Funds reported $31.3M of Global Cord Blood Corporation stock for Q4 2022, down 19% quarter-over-quarter.
- 0 funds opened new Global Cord Blood Corporation positions in Q4 2022 and 1 closed out, a net change of -1 holder.
- The largest Global Cord Blood Corporation buyer in Q4 2022 was Simplex Trading, an estimated $6.3K added.
- The largest Global Cord Blood Corporation seller in Q4 2022 was Morgan Stanley, an estimated $188 sold.
Based on aggregated 13F filings for Q4 2022.